Factors predicting statin prescribing for primary prevention: a historical cohort study.

Finnikin, Samuel; Willis, Brian H; Ryan, Ronan; Evans, Tim; Marshall, Tom

Finnikin, Samuel; Willis, Brian H; Ryan, Ronan; Evans, Tim; Marshall, Tom.

Afiliação

Finnikin S; Institute of Applied Health Research, University of Birmingham, Birmingham.
Willis BH; Institute of Applied Health Research, University of Birmingham, Birmingham.
Ryan R; Public Health England, London.
Evans T; Public Health England, London.
Marshall T; Institute of Applied Health Research, University of Birmingham, Birmingham.

Br J Gen Pract ; 71(704): e219-e225, 2021.

Article em En | MEDLINE | ID: mdl-33558331

Assuntos

Doenças Cardiovasculares; Inibidores de Hidroximetilglutaril-CoA Redutases; Doenças Cardiovasculares/epidemiologia; Doenças Cardiovasculares/prevenção & controle; Estudos de Coortes; Humanos; Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico; Prevenção Primária; Fatores de Risco

Palavras-chave

cardiovascular diseases; cholesterol; decision making, shared; general practice; hydroxymethylglutaryl-CoA reductase inhibitors; risk assessment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google